Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Nutraceuticals and Cardiovascular Disease -

Nutraceuticals and Cardiovascular Disease

An Evidence-based Approach for Clinical Practice
Buch | Hardcover
IX, 300 Seiten
2021 | 1st ed. 2021
Springer International Publishing (Verlag)
978-3-030-62631-0 (ISBN)
CHF 194,70 inkl. MwSt
  • Versand in 15-20 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken

This book provides an evidence-based approach for the clinical use of nutraceuticals in the prevention and management of cardiovascular disease. It examines cardiovascular disease epidemiology, risk factors, and the role of dietary patterns. Clinical chapters discuss the use of nutraceuticals in the management of medical conditions such as dyslipidemia, hypertension, insulin resistance, and heart failure. Each chapter contains a short epidemiological background; a list of relevant active compounds and their efficacy, tolerability, and safety; and suggestions for prescribers. This book is a practical guide with the best clinical evidence supporting the use of nutraceuticals in cardiology.

Nutraceuticals and Cardiovascular Disease: An Evidence-based Approach for Clinical Practice is an essential resource for physicians, residents, fellows, and medical students in cardiology, clinical nutrition, dietetics, and internal medicine.

Arrigo F.G. Cicero, MD, PhD President of the Italian Nutraceutical Society (SINut) Associate Professor of Dietary Sciences Dept. of Medical and Surgical Sciences Alma Mater Studiorum University of Bologna Italy Prof. Manfredi Rizzo, MD, PhD Associate Professor of Internal Medicine Department of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialties (PROMISE) School of Medicine University of Palermo Italy

Chapter 1. Introduction to Cardiovascular Disease Epidemiology and Risk Factors.- Chapter 2. Definition of Nutraceuticals (Both Scientific and Legal).- Chapter 3. Evidence-based Approach to Nutraceuticals in Cardiovascular Medicine.- Chapter 4. Dietary Patterns and Cardiovascular Disease Risk: From Epidemiology to Intervention.- Chapter 5. Single Dietary Components and Cardiovascular Disease Risk: From Epidemiology to Intervention.- Chapter 6. Nutraceuticals for Dyslipidemia Management.- Chapter 7. Nutraceuticals for Hypertension Management.- Chapter 8. Nutraceuticals for Management of Insulin Resistance.- Chapter 9. Nutraceuticals Supporting Body Weight Loss.- Chapter 10. Nutraceuticals for Non-alcoholic Fatty Liver Disease Management.- Chapter 11. Nutraceuticals for Homocysteine Reduction.- Chapter 12. Nutraceuticals Supporting Cognitive Function in Mild Cognitive Impairment.- Chapter 13. Nutraceuticals Supporting Heart Function in Heart Failure.- Chapter 14. Nutraceuticals with Potential Adverse Cardiovascular Events or Pharmacological Interaction with Cardiometabolic Drugs.

Erscheinungsdatum
Reihe/Serie Contemporary Cardiology
Zusatzinfo IX, 300 p. 17 illus., 14 illus. in color.
Verlagsort Cham
Sprache englisch
Maße 155 x 235 mm
Gewicht 703 g
Themenwelt Medizin / Pharmazie Gesundheitsfachberufe Diätassistenz / Ernährungsberatung
Medizinische Fachgebiete Innere Medizin Kardiologie / Angiologie
Schlagworte Cardiovascular disease and nutraceuticals • cardiovascular disease prevention • Dietary supplements and cardiovascular disease • Evidence-based medicine and nutraceuticals • Nutraceuticals and heart failure • Nutraceuticals for cardiovascular disease prevention • Nutraceuticals for dyslipidemia management • Nutraceuticals for hypertension management • Nutraceuticals for management of cardiovascular disease
ISBN-10 3-030-62631-8 / 3030626318
ISBN-13 978-3-030-62631-0 / 9783030626310
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
in Fällen, Fragen und Antworten

von Christoph Spes; Volker Klauss; Sibylle Tönjes

Buch | Softcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 124,60
Diagnostik und interventionelle Therapie | 2 Bände

von Raimund Erbel; Michael Haude; Philipp Kahlert; Björn Plicht …

Buch (2024)
Deutscher Ärzteverlag
CHF 489,95